# Cholangiocarcinoma Foundation 7th Annual Conference

> **NIH NIH R13** · CHOLANGIOCARCINOMA FOUNDATION · 2020 · $5,000

## Abstract

Project Summary
As a rare and lethal disease, cholangiocarcinoma (CCA) lacks attention and resources. There is
a vast unmet need for education across the entire disease spectrum from bench-to-bedside. As
such, the Cholangiocarcinoma Foundation continues to focus its efforts to educate all
stakeholders in the cholangiocarcinoma community-at-large.
Paramount to that effort, the 2020 Annual Conference has been developed with the following
objectives: 1) Increasing the knowledge and understanding of attendees about key issues
central to the prevention, diagnosis, treatment, and cure for cholangiocarcinoma; 2) Identifying
gaps and gathering consensus on rapidly changing advances in basic, translational, and clinical
research; 3) Stimulating international, multi-disciplinary, cross-cooperation and sharing of best
practices by developing, strengthening, and supporting collaborations; 4) Fostering dialogue
and inspiring innovation.
A multidisciplinary audience, including representatives of the scientific, medical and academic
communities; policymakers and regulators, industry, advocates, patients and caregivers will
convene to present a diversity of perspectives focused on evidence-based opinion, compare
current developments, and summarize emerging developments in basic, translational and
clinical research defining the field of CCA.
A global community of experts will review symptoms, incidence, and prevalence in high risk
populations (prevention); examine epidemiological and pathological features of the
heterogeneous group of 3 anatomically distinct cancers (diagnosis); and review advances in
oncology research that are likely to be clinically relevant (treatment and cure).
This setting will also provide a forum to attract and nurture early career researchers with
opportunities to develop and expand their education with mentorship from a global community of
renowned experts. Through oral abstracts, poster sessions, speaker presentations, patient
engagement and more, Young Investigators will forge new alliances, stimulate dialogue and
accelerate global CCA research with the common goal of supporting the Foundation's mission
to find a cure and improve the quality of life for those affected by CCA.

## Key facts

- **NIH application ID:** 9911546
- **Project number:** 1R13CA246934-01
- **Recipient organization:** CHOLANGIOCARCINOMA FOUNDATION
- **Principal Investigator:** Stacie Lindsey
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $5,000
- **Award type:** 1
- **Project period:** 2020-03-01 → 2021-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9911546

## Citation

> US National Institutes of Health, RePORTER application 9911546, Cholangiocarcinoma Foundation 7th Annual Conference (1R13CA246934-01). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/9911546. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*